Market Value1,166,506,000
Total Holdings59
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EPIX / ESSA Pharma Inc.
RPTX / Repare Therapeutics Inc.
ARYBU / ARYA Sciences Acquisition Corp II
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
VINCERA PHARMA INC / UNIT 12/24/2025 (92731L205)
NARI / Inari Medical, Inc.
SAGE / Sage Therapeutics, Inc.
ABCL / AbCellera Biologics Inc.
CRIS / Curis, Inc.
AMTI / Applied Molecular Transport Inc.
HSAQ / Health Sciences Acquisitions Corp 2
HRMY / Harmony Biosciences Holdings, Inc.
OM / Outset Medical, Inc.
NKTX / Nkarta, Inc.
NUVB / Nuvation Bio Inc.
VRDN / Viridian Therapeutics, Inc.
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
/ Cerevel Therapeutics Holdings, Inc. Warrant
FMTX / Forma Therapeutics Holdings Inc
ALGS / Aligos Therapeutics, Inc.
AKUS / Akouos Inc
LUNG / Pulmonx Corporation
GMTX / Gemini Therapeutics Inc
OPT / Opthea Limited - Depositary Receipt (Common Stock)
GBIO / Generation Bio Co.
CCCC / C4 Therapeutics, Inc.
HLXA / Helix Acquisition Corp - Class A
VINC / Vincerx Pharma, Inc.
RLAY / Relay Therapeutics, Inc.
/ EyePoint Pharmaceuticals Inc
AFIB / Acutus Medical, Inc.
ITOS / iTeos Therapeutics, Inc.
EAR / Eargo, Inc.
SBTX / Silverback Therapeutics Inc
BDTX / Black Diamond Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
IGMS / IGM Biosciences, Inc.
/ Therapeutics Acquisition Corp. Class A
NRIX / Nurix Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
PASG / Passage Bio, Inc.
CLDX / Celldex Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
TNGX / Tango Therapeutics, Inc.
/ Pandion Therapeutics Inc
STTK / Shattuck Labs, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
KNTE / Kinnate Biopharma Inc.
PMVP / PMV Pharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
ATHA / Athira Pharma, Inc.
MRTX / Mirati Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
RAPT / RAPT Therapeutics, Inc.
BTAI / BioXcel Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
KROS / Keros Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
DYN / Dyne Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
KALV / KalVista Pharmaceuticals, Inc.
OLMA / Olema Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
TVTX / Travere Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd. Call
PCVX / Vaxcyte, Inc.
PLRX / Pliant Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ANNX / Annexon, Inc.
LRMR / Larimar Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.